These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15506350)

  • 21. Omapatrilat: still a promise in salt-sensitive hypertension?
    Tojo A; Fujita T; Wilcox CS
    J Hypertens; 2003 Jan; 21(1):31-2. PubMed ID: 12544430
    [No Abstract]   [Full Text] [Related]  

  • 22. [Contribution of diuretics to the treatment of hypertension in patients with CKD].
    Ura N; Yamaji I
    Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of the renin-angiotensin system by atrial natriuretic peptide.
    Johnston CI; Phillips PA; Arnolda L; Mooser V
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S43-6. PubMed ID: 1708022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New trends in hypertension management: of salt, going solo and single pill combos.
    Dresser GK; Feldman RD
    Curr Opin Cardiol; 2010 Jul; 25(4):342-9. PubMed ID: 20520538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natriuretic peptides and cardiomyopathy].
    Nishigaki K; Fujiwara H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():95-100. PubMed ID: 15506346
    [No Abstract]   [Full Text] [Related]  

  • 26. [Translational research on adrenomedullin].
    Shimosawa T; Fujita T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():290-5. PubMed ID: 15506389
    [No Abstract]   [Full Text] [Related]  

  • 27. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dual blockade of the renin-angiotensin system].
    Andersen NH; Mogensen CE
    Ugeskr Laeger; 2004 Oct; 166(43):3799-803. PubMed ID: 15544108
    [No Abstract]   [Full Text] [Related]  

  • 29. Omapatrilat for the management of heart failure and hypertension.
    Husereau DR
    Issues Emerg Health Technol; 2001 Jun; (17):1-4. PubMed ID: 11776285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of hypertension in the progression of diabetic microangiopathy].
    Kamide K; Rakugi H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():98-102. PubMed ID: 15999692
    [No Abstract]   [Full Text] [Related]  

  • 33. A vaccine for hypertension.
    Ménard J
    J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vasopeptidase inhibitors. Omapatrilat in hypertension and heart failure].
    Heinzl S
    Med Monatsschr Pharm; 2000 Feb; 23(2):38-41. PubMed ID: 10701306
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined neutral endopeptidase inhibitors.
    Cuculi F; Erne P
    Expert Opin Investig Drugs; 2011 Apr; 20(4):457-63. PubMed ID: 21323474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasopeptidase inhibitors and their potential role in diabetes.
    Chowdhury TA; Khan T
    Diabetes Obes Metab; 2002 Mar; 4(2):89-95. PubMed ID: 11940105
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypertension in patients with cardiac hypertrophy].
    Kohno M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():471-7. PubMed ID: 15171418
    [No Abstract]   [Full Text] [Related]  

  • 39. Determinants of diastolic dysfunction: a geometric matter?
    Fava C
    Am J Hypertens; 2007 Apr; 20(4):416. PubMed ID: 17386349
    [No Abstract]   [Full Text] [Related]  

  • 40. [Natriuretic peptides in patients with ischemic heart disease].
    Yoshimura M; Ogawa H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():88-92. PubMed ID: 15506344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.